Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motivational Interviewing × Breast × Clear all

Phase

Status

Completed 6 Unknown 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Patient Compliance 1 Breast Neoplasms 1

Interventions

Fulvestrant 75 pembrolizumab 74 Carboplatin 69 Capecitabine 67 Trastuzumab 65 Letrozole 60 Cyclophosphamide 59 Paclitaxel 56 Specimen Handling 53 Docetaxel 49 pertuzumab 47 ribociclib 46 abemaciclib 45 trastuzumab deruxtecan 35 Magnetic Resonance Spectroscopy 34 Anastrozole 34 130-nm albumin-bound paclitaxel 34 Blood Specimen Collection 33 sacituzumab govitecan 31 Tamoxifen 31 Biopsy 30 Surveys and Questionnaires 29 exemestane 28 Gemcitabine 28 Epirubicin 28 pyrotinib 27 palbociclib 27 Injections 27 Drug Therapy 27 eribulin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06635005 2025-10-16

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡